News

The FDA approval is based on results from the Phase III AURELIA trial that showed Avastin plus chemotherapy reduced the risk of disease worsening or death (progression-free survival)

These results will be presented in a poster presentation this evening at 7:30 PM ET at the 19th Annual Scientific Meeting and Education Day of the Society for

Initial results are being presented this weekend to clinicians convening during the American Heart Association meeting held in Chicago, including a meeting of the Association of Black Cardiologists.

The round includes initial angel and strategic investors and new investors Hillhouse Capital and CITIC Capital Partners, as well as an undisclosed blue chip U.S. public investment fund

This online proprietary platform: Emphasizes regulatory compliance of finished products Highlights quality assurance programs to prospective clients Showcases compliance to retailer programs The global economy and increased overseas

Pembrolizumab is a humanized monoclonal antibody that blocks the interaction between PD-1 and its ligands PD-L1 and PD-L2. The trial evaluated pembrolizumab at doses of 2mg/kg every three

Highlights • Lusomedicamenta, together with its subsidiary, had twelve month revenues and adjusted EBITDA for non-recurring items to end September 2014 of EUR 50.7million (SEK 456.3 million) and

The company said that due to its safety profile, the use of Lemtrada should be reserved for patients who have had an inadequate response to two or more

The new 30,000m² facility, to be built on the grounds of the company’s existing bulk pharmaceutical manufacturing plant, will house six 15,000l bioreactors, purification area as well as